Haemonetics | HAE - Net Income


Haemonetics reported $46.3M in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
Baxter International USD 294M 168M Sep/2026
Becton, Dickinson and Co. USD 696M 319M Sep/2026
Boston Scientific USD 582M 325M Sep/2026
Cerus USD -20.92M 17.98M Dec/2024
Cooper Companies USD 432.8M 510.7M Jun/2026
Fresenius EUR 371M 11M Sep/2026
Fresenius Medical Care EUR 160M 58.38M Sep/2026
Globus Medical USD 141.17M 10.4M Sep/2026
Haemonetics USD 46.3M 13.3M Sep/2026
ICU Medical USD 19.09M 11.04M Jun/2026
Intuitive Surgical USD 522.8M 295.3M Sep/2026
Medtronic USD 1.47B 227M Jun/2026
Merit Medical Systems USD 38.8M 2.19M Jun/2026
Neogen USD -11.9M 600K Jun/2026
OraSure Technologies USD -19.29M 5.57M Dec/2025
Plus Therapeutics USD -6.95M 1.23M Mar/2026
Quidel USD -53.8M 39.1M Sep/2026
ResMed USD 383.43M 15.3M Jun/2026
STAAR Surgical USD 5.58M 2.48M Sep/2026
Steris USD 213.7M 13.6M Sep/2026
Stryker USD 1.28B 531M Jun/2026
Teleflex USD 927.43M 827.73M Sep/2026
Terumo JPY 70.43B 44.06B Jun/2026
Thermo Fisher Scientific USD 1.72B 15M Sep/2026
US Physical Therapy USD 11.04M 1.15M Sep/2026
Zimmer Biomet Holdings USD 191.6M 6.7M Sep/2026